As of 2025-05-22, the Relative Valuation of Hollister Biosciences Inc (HOLL.CN) is 0.02 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 CAD, the upside of Hollister Biosciences Inc based on Relative Valuation is -88.3%.
The range of the Relative Valuation is 0.01 - 0.04 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.9x - 2.8x | 1.1x |
| Forward P/E multiples | 0.9x - 2.8x | 1.1x |
| Fair Price | 0.01 - 0.04 | 0.02 |
| Upside | -90.4% - -70.7% | -88.3% |
| Date | P/E |